NCT03658902 (BotuREA) is a clinical trial in Botulism; Poisoning, sponsored by Centre Hospitalier le Mans.

Who is sponsoring NCT03658902?

NCT03658902 is sponsored by Centre Hospitalier le Mans.

What condition does NCT03658902 study?

NCT03658902 studies Botulism; Poisoning.

Is NCT03658902 still recruiting?

NCT03658902 is currently completed. Last updated 6 September 2018.

Last reviewed 2018-09-06 · How we verify

NCT03658902: BotuREA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrospective Epidemiological Study on Botulism in Intensive Care Units in France

Completed Last updated 6 September 2018

What this trial tests

trial in Botulism; Poisoning in 52 participants. Completed in 15 August 2018.

Timeline

1 January 2000

Primary endpoint
31 December 2017

15 August 2018

Quick facts

Lead sponsor	Centre Hospitalier le Mans
Status	Completed
Study type	OBSERVATIONAL
Enrollment	52
Start date	1 January 2000
Primary completion	31 December 2017
Estimated completion	15 August 2018

Conditions studied

Botulism; Poisoning — all drugs for Botulism; Poisoning →

Sponsor

Centre Hospitalier le Mans

Who can join

15 and older, any sex, with Botulism; Poisoning. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Botulism poisoning is a rare but serious illness. Because of it's low incidence, it is not well known by physicians. Most studies describing botulism date back to the last century and do not take into account recent advances in intensive care. The objective of this study is to describe the clinical course, interventions and outcomes of patients with severe botulism poisoning requiring a hospitalisation in an intensive care or high dependancy unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier le Mans trials

Trials by the same sponsor.

NCT07365644 — Prophylactic ANTicoagulation With HEparine in Critically Ill Patients With Renal Impairment · not yet recruiting
NCT07301957 — Impact of Early Rupture of the Residual Membrane on Latency Before Labour Begins · NA · not yet recruiting
NCT07458477 — Digital Audiometer vs. Conventional Audiometer (Gold Standard): Study of Tonal and Vocal Recognition Thresholds · NA · recruiting
NCT06799806 — The Impact of the Therapeutic Virtual Reality Headset on Patient Anxiety in the Waiting Room Before Flexible Bronchoscop · NA · recruiting
NCT05915663 — Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03658902 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier le Mans
Last refreshed: 6 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03658902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing